Skip to main navigation Skip to search Skip to main content

Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: A single institution experience from the Robert H. Lurie Comprehensive Cancer Center

  • Christiane Querfeld
  • , Neha Mehta
  • , Steven T. Rosen
  • , Joan Guitart
  • , Alfred Rademaker
  • , Pedram Gerami
  • , Timothy M. Kuzel

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: A single institution experience from the Robert H. Lurie Comprehensive Cancer Center'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology